Results 111 to 120 of about 14,852 (255)

Non-neoplastic diseases of the fallopian tube: MR imaging with emphasis on diffusion-weighted imaging [PDF]

open access: gold, 2016
Pietro Valerio Foti   +7 more
openalex   +1 more source

Rare Presentation of a Viable Secondary Abdominal Ectopic Pregnancy in the Rudimentary Horn of a Bicornuate Uterus: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT An advanced abdominal in a rudimentary horn pregnancy is rare and difficult to diagnose, especially in late gestation. Accurate early recognition, multidisciplinary planning, and preoperative vascular interventions are critical. With precise surgical management, even in high‐risk scenarios, favorable maternal and neonatal outcomes can be ...
Shazia Fakhar   +4 more
wiley   +1 more source

Rapidly Growing Mucinous Cystadenoma in a 13‐Year‐Old Premenarchal Female: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Mucinous cystadenomas are rare ovarian tumors in premenarchal girls but can present as rapidly growing large abdominal masses causing obstructive symptoms. Early recognition and timely surgical intervention, often requiring salpingo‐oophorectomy, are crucial to prevent complications.
Zeina Marzouk   +7 more
wiley   +1 more source

Ovarian Sex Cord Stromal Tumor With Annular Tubules: A Rare Diagnosis in Young Women

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Ovarian sex cord‐stromal tumor with annular tubules (SCTAT) is a rare neoplasm with distinct clinicopathological features in its sporadic and syndromic forms, the latter commonly associated with Peutz‐Jeghers syndrome. Although imaging may suggest a sex cord‐stromal origin, definitive diagnosis relies on histopathological examination.
Prescillia Marques   +3 more
wiley   +1 more source

Targeting neutrophil‐driven immunosuppression: A strategy to overcome immune checkpoint inhibitor resistance

open access: yesClinical and Translational Medicine, Volume 16, Issue 1, January 2026.
TANs drive ICI resistance via antitumour immune remodelling, angiogenesis promotion, and elevation of tumour mutation burden Neutrophil biomarkers (e.g., NLR, TAN abundance) show strong predictive value for ICI response and prognosis. Targeting TAN recruitment, polarization, function and NETosis represents a promising strategy to overcome ICI ...
Ying Ning   +7 more
wiley   +1 more source

Synthetic lethality in cancer therapy: Mechanisms, models and clinical translation for overcoming therapeutic resistance

open access: yesClinical and Translational Medicine, Volume 16, Issue 1, January 2026.
Application of synthetic lethality screening in drug resistance models. Abstract Background and Rationale Synthetic lethality (SL)‐based strategies hold significant promise for overcoming therapeutic resistance, a critical bottleneck in cancer treatment where cancer cells evade anticancer therapies, leading to diminished efficacy or treatment failure ...
Junyan Li   +4 more
wiley   +1 more source

Treatment Strategy and Residual Disease as Determinants of Survival in Stage IVB High‐Grade Serous Ovarian Cancer: A Retrospective Cohort Study

open access: yesJournal of Surgical Oncology, Volume 133, Issue 1, Page 73-80, January 2026.
ABSTRACT Background and Objective Stage IVB high‐grade serous ovarian cancer (HGSOC) carries a poor prognosis. We aimed to: (1) describe the characteristics and survival of patients treated with primary cytoreductive surgery (PCS), interval cytoreductive surgery (ICS) or chemotherapy alone, (2) investigate the correlation between disease distribution ...
Anouk Benseler   +6 more
wiley   +1 more source

The Role of Macrophages in Cancer: From Basic Research to Clinical Applications

open access: yesMedComm, Volume 7, Issue 1, January 2026.
Monocytes infiltrate the tumor microenvironment (TME) and differentiate into macrophages, which polarize into proinflammatory, antitumor M1 cells or immunosuppressive, protumor M2 cells. Within the TME, M2‐type tumor‐associated macrophages (TAMs) predominate and drive tumor growth, angiogenesis, and metastasis. Therapeutic strategies therefore focus on
Zhimei Liu   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy